J. M. van Rossum. Significance of pharmacokinetics for drug design and the planning of dosage regimens. In Ariëns, E. J. (ed.),Drug Design, Vol. 1, Academic Press, New York, 1971, pp. 469–521.
F. Lundquist and H. Wolthers. The kinetics of alcohol elimination in man.Acta Pharmacol. Toxicol. 14:265–289 (1958).
H. W. Haggard, L. A. Greenberg, and R. P. Carrol. Studies in the absorption, distribution and elimination of alcohol. VIII. The diuresis from alcohol and its influence on the elimination of alcohol in the urine.J. Pharmacol. Exptl. Therap. 71:348–357 (1941).
G. Levy, T. Tsuchiya, and L. P. Amsel. Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man.Clin. Pharmacol. Therap. 13:258–268 (1972).
J. G. Wagner. Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics.J. Pharmacokin. Biopharm. 1:103–121 (1973).
J. G. Wagner.Biopharmaceutics and Relevant Pharmacokinetics, Drug Intelligence Publications, Hamilton, Ill., 1971, p. 294.
J. G. Wagner and A. Patel. Variations in absorption and elimination rates of ethyl alcohol in a single subject.Res. Commun. Chem. Pathol. Pharmacol. 4:61–76 (1972).
C. S. Lieber. Liver adaptation and injury in alcoholism.New Engl. J. Med. 268:356–362 (1973).
A. J. Glazko, T. Chang, J. Baukema, W. A. Dill, J. R. Goulet, and R. A. Buchanan. Metabolic disposition of diphenylhydantoin in normal human subjects following intravenous administration.Clin. Pharmacol. Therap. 10:498–504 (1969).
J. J. Ashley and G. Levy. Kinetics of diphenylhydantoin elimination in rats.J. Pharmacokin. Biopharm. 1:99–102 (1973).
W. S. van der Pol, R. Deeleman, E. van der Kleijn, M. Lauw, H. Schönefeld, J. M van Rossum, and J. F. Crul. Linear and non-linear pharmacokinetics of 4-hydroxybutyrate in humans. To be published.